Jessica

Testing for Guanidinoacetate Methyltransferase (GAMT) deficiency

The Florida Department of Health, Newborn Screening (NBS) Program, is pleased to announce that as of January 2025, all newborns are being screened for Guanidinoacetate methyltransferase (GAMT) deficiency through the newborn screening process.  If you have any questions, please contact

Testing for Mucopolysaccharidosis Type II (MPS II)

The Florida Department of Health, Newborn Screening (NBS) Program, is pleased to announce that beginning July 1, 2024, all newborns screened will be tested for Mucopolysaccharidosis Type II (MPS II).  If you have any questions, please contact the Florida NBS